Replies to post #116252 on Biotech Values

[DewDiligence]

You fail to mention that Truvada was the SOC in HIV before the release of Atripla.

It was no such thing. Before Atripla, the standard of care in HIV was Truvada in conjunction with either a protease inhibitor or a non-nuke.